Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis

AIDS Research and Therapy

Volumn 7, Issue , 2010, Pages

  Cachay, Edward R ^a   Caperna, Joseph ^a   Sitapati, Amy M ^a   Jafari, Hamta ^b   Kandel, Sean ^c   Mathews, William C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ALAMEDA COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; FLUCYTOSINE; FUNGUS ANTIGEN;

ADULT; AGED; AIDS RELATED COMPLEX; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 77955109979     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-7-29     Document Type: Article

References (14)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-30. 10.1097/QAD.0b013e328322ffac, 19182676.
2. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009, 48:856-62. 10.1086/597262, 2875173, 19222372.
3. Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: reference interval and the effect of body mass index. Neurology 2006, 67:1690-1. 10.1212/01.wnl.0000242704.60275.e9, 17101909.
4. Hamilton JR, Noble A, Denning DW, Stevens DA. Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J Clin Microbiol 1991, 29:333-9. 269763, 2007642.
5. Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007, 115:654-7. 10.1161/CIRCULATIONAHA.105.594929, 17283280.
6. Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS 2007, 21:2119-29. 10.1097/QAD.0b013e3282a4a64d, 18090038.
7. Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007, 4:e21. 10.1371/journal.pmed.0040021, 1808080, 17284154.
8. Loyse A, Wainwright H, Jarvis JN, et al. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS 2010, 24:405-10. 10.1097/QAD.0b013e328333c005, 19952714.
9. Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009, 23:701-6.
10. Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007, 45:555-9. 10.1097/QAI.0b013e31811ed32c, 17577124.
11. Liechty CA, Solberg P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health 2007, 12:929-35.
12. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000, 30:47-54. 10.1086/313603, 10619732.
13. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. ClinInfectDis 2010, 50:291-322.
14. Robinson PA, Bauer M, Leal MA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999, 28:82-92. 10.1086/515074, 10028076.